4.3 Article

Reporting of clinical trial safety results in ClinicalTrials.gov for FDA-approved drugs: A cross-sectional analysis

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

The Culture of Trial Results Reporting at Academic Medical Centers

Deborah A. Zarin

JAMA INTERNAL MEDICINE (2020)

Article Computer Science, Information Systems

Is it time for computable evidence synthesis?

Adam G. Dunn et al.

JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2020)

Letter Medicine, General & Internal

Association Between Data Sources and US Food and Drug Administration Drug Safety Communications

Noam Tau et al.

JAMA INTERNAL MEDICINE (2019)

Article Medicine, General & Internal

10-Year Update on Study Results Submitted to ClinicalTrials.gov

Deborah A. Zarin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis

Chris A. Rees et al.

PLOS MEDICINE (2019)

Article Medicine, General & Internal

Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010

Nicholas S. Downing et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Article Medicine, General & Internal

Update on Trial Registration 11 Years after the ICMJE Policy Was Established

Deborah A. Zarin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Medicine, General & Internal

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials

Lisa M. Schwartz et al.

ANNALS OF INTERNAL MEDICINE (2016)

Article Medicine, General & Internal

Trial Reporting in ClinicalTrials.gov - The Final Rule

Deborah A. Zarin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Medicine, General & Internal

Compliance with Results Reporting at ClinicalTrials.gov

Monique L. Anderson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Reporting Discrepancies Between the ClinicalTrials.gov Results Database and Peer-Reviewed Publications

Daniel M. Hartung et al.

ANNALS OF INTERNAL MEDICINE (2014)

Article Health Care Sciences & Services

Era Of Faster FDA Drug Approval Has Also Seen Increased Black-Box Warnings And Market Withdrawals

Cassie Frank et al.

HEALTH AFFAIRS (2014)

Letter Medicine, General & Internal

Reporting of Results in ClinicalTrials.gov and High-Impact Journals

Jessica E. Becker et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)

Article Medicine, General & Internal

Non-publication and delayed publication of randomized trials on vaccines: survey

Lamberto Manzoli et al.

BMJ-BRITISH MEDICAL JOURNAL (2014)

Article Pharmacology & Pharmacy

The Future of Population-Based Postmarket Drug Risk Assessment: A Regulator's Perspective

T. A. Hammad et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)

Article Pharmacology & Pharmacy

Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System

R. Harpaz et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)

Article Pharmacology & Pharmacy

The Practice of Pre-Marketing Safety Assessment in Drug Development

Christy Chuang-Stein et al.

JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2013)

Article Medicine, General & Internal

Timing and Completeness of Trial Results Posted at ClinicalTrials.gov and Published in Journals

Carolina Riveros et al.

PLOS MEDICINE (2013)

Editorial Material Medicine, General & Internal

A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions Opportunities Provided by a New IOM Report

Bruce M. Psaty et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Editorial Material Cardiac & Cardiovascular Systems

The rise and fall of rosiglitazone

Steven E. Nissen

EUROPEAN HEART JOURNAL (2010)

Review Medicine, General & Internal

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

Isabelle Pitrou et al.

ARCHIVES OF INTERNAL MEDICINE (2009)

Editorial Material Medicine, General & Internal

The New Sentinel Network - Improving the Evidence of Medical-Product Safety

Richard Platt et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis

Joseph S. Ross et al.

PLOS MEDICINE (2009)

Article Medicine, General & Internal

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

P Juni et al.

LANCET (2004)

Article Medicine, General & Internal

Better reporting of harms in randomized trials: An extension of the CONSORT statement

JPA Ioannidis et al.

ANNALS OF INTERNAL MEDICINE (2004)